These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 18369817)

  • 21. Telomeres, senescence, and hematopoietic stem cells.
    Zimmermann S; Martens UM
    Cell Tissue Res; 2008 Jan; 331(1):79-90. PubMed ID: 17960423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
    Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J
    Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation: effect of p53.
    Ju YJ; Park JE; Juhn KM; Jeong J; Yun M; Park MJ; Park GH; Choi KY; Cho MH; Wong KK; Park WB; Lee KH
    Int J Oncol; 2006 Oct; 29(4):753-63. PubMed ID: 16964373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
    Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
    Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic profiling in distinct cellular compartments of tumor cells reveals p53-dependent upregulation of S100A6 upon induction of telomere dysfunction.
    Zimmermann S; Biniossek ML; Maurer C; Münzer P; Pantic M; Veelken H; Martens UM
    Proteomics; 2009 Nov; 9(22):5175-87. PubMed ID: 19834903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins.
    Potts PR; Yu H
    Nat Struct Mol Biol; 2007 Jul; 14(7):581-90. PubMed ID: 17589526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of telomerase activity and telomere function in cancer.
    Gordon KE; Parkinson EK
    Methods Mol Biol; 2004; 281():333-48. PubMed ID: 15220541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening of telomerase inhibitors.
    Kleideiter E; Piotrowska K; Klotz U
    Methods Mol Biol; 2007; 405():167-80. PubMed ID: 18369824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telomere and telomerase as targets for cancer therapy.
    Tian X; Chen B; Liu X
    Appl Biochem Biotechnol; 2010 Mar; 160(5):1460-72. PubMed ID: 19412578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies.
    Hills M; Lansdorp PM
    Ann N Y Acad Sci; 2009 Sep; 1176():178-90. PubMed ID: 19796246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of telomerase to create bioengineered tissues.
    Shay JW; Wright WE
    Ann N Y Acad Sci; 2005 Dec; 1057():479-91. PubMed ID: 16399914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomere dysfunction and telomerase activation in cancer--a pathological paradox?
    Calcagnile O; Gisselsson D
    Cytogenet Genome Res; 2007; 118(2-4):270-6. PubMed ID: 18000380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomeres, telomerase, and hematopoietic stem cell biology.
    Greenwood MJ; Lansdorp PM
    Arch Med Res; 2003; 34(6):489-95. PubMed ID: 14734088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The roles of telomeres and telomerase in cellular immortalization and the development of cancer.
    Klingelhutz AJ
    Anticancer Res; 1999; 19(6A):4823-30. PubMed ID: 10697595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new steroid derivative stabilizes g-quadruplexes and induces telomere uncapping in human tumor cells.
    Brassart B; Gomez D; De Cian A; Paterski R; Montagnac A; Qui KH; Temime-Smaali N; Trentesaux C; Mergny JL; Gueritte F; Riou JF
    Mol Pharmacol; 2007 Sep; 72(3):631-40. PubMed ID: 17586599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas.
    Scheel C; Schaefer KL; Jauch A; Keller M; Wai D; Brinkschmidt C; van Valen F; Boecker W; Dockhorn-Dworniczak B; Poremba C
    Oncogene; 2001 Jun; 20(29):3835-44. PubMed ID: 11439347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
    Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silencing PinX1 compromises telomere length maintenance as well as tumorigenicity in telomerase-positive human cancer cells.
    Zhang B; Bai YX; Ma HH; Feng F; Jin R; Wang ZL; Lin J; Sun SP; Yang P; Wang XX; Huang PT; Huang CF; Peng Y; Chen YC; Kung HF; Huang JJ
    Cancer Res; 2009 Jan; 69(1):75-83. PubMed ID: 19117989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
    Rankin AM; Faller DV; Spanjaard RA
    Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomeres and telomerase in hematologic neoplasia.
    Ohyashiki JH; Sashida G; Tauchi T; Ohyashiki K
    Oncogene; 2002 Jan; 21(4):680-7. PubMed ID: 11850796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.